R. Ong

Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databases

P. Biedermann, A. Davydov, G. Wetherill, 2021, BMC Medical Research Methodology.

SAFETY OF MACITENTAN IN PULMONARY HYPERTENSION PATIENTS WITH ELEVATED PULMONARY CAPILLARY WEDGE PRESSURE: REAL-WORLD EVIDENCE FROM OPUS/ORPHEUS

V. McLaughlin, K. Chin, R. Channick, 2021, Chest.

TREATMENT PATTERNS IN PULMONARY ARTERIAL HYPERTENSION: CHANGES IN CLINICAL PRACTICE OVER TIME USING REAL-WORLD EVIDENCE FROM THE COMBINED OPUS/ORPHEUS DATA SETS

V. McLaughlin, K. Chin, R. Channick, 2020 .

Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study

V. Muthurangu, D. Kiely, L. Howard, 2023, European heart journal.

Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset

R. Zamanian, Richard Channick, S. Turricchia, 2024, Cardiology and therapy.